Anti-Inflammatory Therapeutic Effect of Tegoprazan in Spinal Cord-Injured Rats
Abstract
Background: Spinal cord injury (SCI) can induce secondary damage, such as inflammation, oxidative stress, and neuronal cell death. These factors impede recovery. This study evaluated the therapeutic potential of tegoprazan (TEGO), a drug known to act via a potassium-competitive acid blocker, in a SCI rat model. Methods: We conducted SCI in female rats, and TEGO was administered intraperitoneally. Methylprednisolone (MP) was used as a positive control. TEGO was dissolved in dimethyl sulfoxide (DMSO) and sonicated before injection. Toxicity was assessed by body weight monitoring, and motor recovery was assessed by behavioral tests. We performed immunofluorescence and qRT-PCR to investigate inflammatory markers. Western blot analyses were evaluated for mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) signaling pathways. Results: TEGO treatment had no systemic toxicity and improved motor recovery. TEGO (p < 0.05) and MP (p < 0.01) decreased inducible nitric oxide synthase (iNOS) expression. CD206 expression was significantly increased in the MP group (p < 0.01) compared with the Vehicle group, whereas the TEGO group showed a slight increase compared with the Vehicle group. Furthermore, TEGO inhibited MAPK/NF-κB signaling, attenuating pro-inflammatory cytokine production. Conclusions: TEGO, a representative potassium-competitive acid blocker (P-CABs), suppressed pro-inflammatory gene expression and might be applied as a novel treatment for SCI.
Read the paper
Related studies
- Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
- Occupation and risk of severe COVID-19: prospective cohort study of 120,075 UK Biobank participants
- Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study
- Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.